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Background: Maternal diabetes mellitus not only has severe deleterious effects on fetal development, but also it
affects transmission to the next generation. However, the underlying mechanisms for these effects are still not clear.
Methods: We investigated the methylation patterns and expressions of the imprinted genes Peg3, Snrpn, and H19
in mid-gestational placental tissues and on the whole fetus utilizing the streptozotocin (STZ)-induced hyperglycemic
mouse model for quantitative analysis of methylation by PCR and quantitative real-time PCR. The protein expression
of Peg3 was evaluated by Western blot.
Results: We found that the expression of H19 was significantly increased, while the expression of Peg3 was
significantly decreased in dpc10.5 placentas of diabetic mice. We further found that the methylation level of Peg3
was increased and that of H19 was reduced in dpc10.5 placentas of diabetic mice. When pronuclear embryos of
normal females were transferred to normal/diabetic (NN/ND) pseudopregnant females, the methylation and
expression of Peg3 in placentas was also clearly altered in the ND group compared to the NN group. However,
when the pronuclear embryos of diabetic female were transferred to normal pesudopregnant female mice (DN),
the methylation and expression of Peg3 and H19 in dpc10.5 placentas was similar between the two groups.
Conclusions: We suggest that the effects of maternal diabetes on imprinted genes may primarily be caused by the
adverse uterus environment.
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Infants of mothers with pre-existing types 1, 2 or gesta-
tional diabetes have significantly higher rates of perinatal
mortality and major congenital anomaly [1,2]. Diabetic
embryopathy can affect many organ systems including the
heart and the neural tube [3-5]. The effects of maternal dia-
betes mellitus on fetal development have been studied in
various animal models. In drug-induced animal models,
embryo development was disturbed by maternal hypergly-
caemia [6,7]. In non-obese diabetic (NOD) mouse models* Correspondence: sunqy@ioz.ac.cn; luckyzcl@qq.com
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stated.of spontaneous type 1 diabetes mellitus, only 20% of recov-
ered NOD embryos reached the blastocyst stage at 96
hours of superovulation compared with 90% of embryos re-
covered from nondiabetic animals [6].
Several reports have shown that teratogenesis may be
a direct result of hyperglycemia [8,9]. Previous studies
found that expressions of genes related to metabolism,
development and signal transduction were altered in
embryos by the diabetic environment [10,11]. Moley
et al. showed that the mRNA and protein expression of
the glucose transporters GLUT-1, GLUT-2, and GLUT-3
were decreased in embryos from streptozotocin (STZ)-
induced hyperglycaemic mice [12]. These results partly
elucidate how maternal diabetes mellitus causes abnor-
mal embryo development. But it is still not clear how
the adverse effects are inherited to the next generations.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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histone acetylation via the citrate lyase pathway [13].
This finding suggests the possibility that the epige-
nome of the embryo may contribute significantly to
abnormal fetal development in diabetic females.
DNA methylation, one of the epigenetic modifica-
tions on DNA, can regulate relative gene expression,
X-chromosome inactivation, as well as genomic im-
printing [14]. Genomic imprinting includes the for-
mation of DNA methylation at specific loci in a
parent-of-origin-specific manner [15]. If DNA methy-
lation on imprinted genes is not acquired/maintained
properly, embryonic development and the offspring’s
health would be affected [16,17].
The DNA methylation pattern of imprinted genes
is susceptible to being affected by the en-
vironment [18]. Several reports have shown that pre-
implantation culture and manipulation can cause an
abnormal methylation status of Differentially Methyl-
ated Regions (DMRs) at imprinted loci and these
changes may induce abnormal fetal development
[19-21]. If maternal nutrients are altered the DNA
methylation patterns may also be changed and this
will induce abnormalities during fetal development.
During gestation, if female rats are fed with choline-
deficient diets, the DNA methylation of G9a and
Suv39h1 is mis-regulated [22]. These data indicate
that the adverse maternal environment exerts ad-
verse effects on DNA methylation during genomic
imprinting establishment and maintenance.
We hypothesized that impaired DNA methylation
at imprinted loci may play a key role in causing ab-
normal embryo development in maternal diabetes
mellitus. In our lab, we have found that the DNA
methylation patterns in DMRs of imprinted genes
Peg3, Snrpn and H19 in oocytes was not altered by
maternal diabetes at 15 days of injection of STZ
[23], but the embryonic development was affected.
This indicated that the uterus environment may have
deleterious effects on embryonic development. We
examined the methylation patterns of DMRs of Peg3,
Snrpn, and H19 in day post-coitum (dpc)10.5 pla-
centa and fetus in the STZ-induced mouse model.
We found that the expression and methylation levels
of the imprinted genes were altered by maternal dia-
betes mellitus in placentas at 10.5dpc of gestation.
Previous studies have shown that if the pre-
gestational type 1 diabetes mellitus was cured at pre-
pregnancy, the risks of adverse pregnancy outcomes
was reduced in women [24]. In animal models, if
diabetic females were treated with insulin, embryonic
development was not significantly different from that
in non-diabetic females [6]. Therefore, we also inves-
tigated whether the adverse effects caused bymaternal diabetes on imprinted genes in placentas
could be corrected by embryo transfer.
Methods
Ethics statement
All procedures described were reviewed and approved
by the ethical committee of the Institute of Zoology,
Chinese Academy of Sciences.
All mice were provided by the Beijing Vital River Ex-
perimental Animals Centre and fed in a temperature
controlled room with a light cycle of 12 L: 12D (light:
dark).
Generation of the diabetic mouse model
Female CD-1® (strain code; 022) mice, aged 6–7 weeks,
received a single intraperitoneal injection of streptozoto-
cin (STZ) at a dose of 230 mg/kg [25]. Four days later,
blood glucose levels were checked using a glucometer,
Blood Testing Equipment, Accu-CHEK Active (Roche
Diagnostic, Germany). If glucose levels were higher than
17.0 mmol/l, the mice were selected and used as the dia-
betic model (diabetic mice n = 53). Mice of similar age
injected with buffer were selected as control (non-dia-
betic mice n = 49).
Collecting placentas and fetuses at mid-gestation
Diabetic/nondiabetic mice were mated naturally with
normal male mice within 15 days of STZ/buffer injection
and were determined to be pregnant when the vaginal
plug was examined at 0.5d. At 10.5d of gestation, placen-
tas (trophoblast population) and whole fetuses were col-
lected. Samples were frozen immediately in liquid
nitrogen and stored at −80°C until used.
DNA purification and quantitative analysis of methylation
by PCR (qAMP)
DNA was purified from one half of the bisected fetus or
placentas using DNA Tissue Kit (Tiangen, China) fol-
lowing the manufacturer’s directions. To investigate the
methylation conditions, qAMP was conducted as de-
scribed by Oakes et al. and Lopes et al. [26,27]. Briefly,
fetal or placental DNA (~1.5 μg/enzyme) was digested
with methylation-sensitive (HhaI, New England Biolabs,
Beijing, China; HpaII, New England Biolabs, Beijing,
China) and methylation-dependent (McrBc, New
England Biolabs, Beijing, China) restriction enzymes, re-
spectively. The resulting product was used as template
for real-time PCR reaction using the SYBR green kit
(Kangwei Inc., China). The qAMP was performed
employing a Rotor-Gene Q Real-Time PCR instrument
(Qiagen). The percentage of methylation for cytosine-
phosphate-guanine (CpG) sites was based on ⊿Ct (cycle
threshold values between digested and undigested sham
aliquots). For HhaI, the percent methylation is 100
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(1- e-0.7(ΔCt)). The primers described in Table 1 were de-
signed to span ~ 180 bps of the DMRs of the maternally
methylated sequences: Peg3 and Snrpn, as well as the pa-
ternally methylated H19.
RNA isolation and mRNA expression assays
RNA was extracted from the other half of the bisected
fetus and placentas using RNA Tissue kit (Tiangen,
China) according to the manufacturer’s instructions.
cDNA first-strand synthesis was performed using Super-
script II (Invitrogen). The first-strand cDNA was used as
template and the expressions of Peg3, Snrpn and H19
were evaluated by quantitative real-time PCR (qRT-PCR)
using Rotor-gen Q (Qiagen, Germany). Triple reactions
were analyzed for each sample and the threshold cycle
value was normalized to the housekeeping gene of pepti-
dylprolyl isomerase A (Ppia). The primers are shown in
Table 1. The expression levels were calculated using the
2-△△Ct method.
Western blot and immunohistochemistry analysis
Placental proteins (n = 6 from 4 litters) were extracted
from cell lysis and quantified for western blot analysis as
previously described [28]. Briefly, proteins were heated
for 5 min at 100°C. Then proteins were separated by
SDS-PAGE and electrically transferred to polyvinylidene
fluoride membranes. After that, the membranes were
blocked in TBST containing 5% skimmed milk for 2 h,
followed by incubation overnight at 4°C with rabbit anti-
peg3 (1:500, Bioss, China, code: bs-1870R). After washed
with TBST, membranes were incubated with goat anti-
rabbit IgG (1:1000) for 1 h at 37°C. Beta-actin was used
as loading control.
For immunohistochemistry analysis, fresh placentas
(n = 6 from 4 litters) were fixed in 4% paraformaldehyde
overnight at 4°C and washed in 50% ethanol for 1 hour
at room temperature. After that, samples were stored in
70% ethanol at 4°C until used. The fixed samples wereTable 1 Oligonucleotides and annealing temperature utilized
Forward
qAMP H19 5′-AGCCGTTGTGAG
Snrpn 5′-CTCCTCAGAACC
Peg3 5′-GGTGTCCCGCA
chr9:106724005-106724149 5′-GATCTATTCCTT
Peg3 qRT-PCR 5′-TTGGACTGGACA
Snrpn 5′-AGGCCCATCCCA
H19 5′- CTTGTCGTAGA
Ppia 5′- CGCGTCTCCTTCdehydrated in a graded ethanol series, cleared in xylene,
and embedded in paraffin wax. The embedded placentas
were sectioned at 8 μm and incubated with rabbit
anti-Peg3 (1:500, Bioss, China, code: bs-1870R) over-
night at 4°C. The samples were then incubated with
the biotin-labeled secondary antibody for 30 minutes.
Staining was carried out using the Vectastain ABC kit
and DAB peroxidase substrate kit (Vector Laboratories,
Burlingame, CA).
Embryo transfer
To obtain pronuclear stage embryos from diabetic and non-
diabetic mice, the estrous female diabetic/ non-diabetic mice
were naturally mated with normal males, respectively.
Vaginal plug was examined the next morning. The mice
with a vaginal plug were killed and the pronuclear em-
bryos were collected from their oviductal ampullae.
To transfer embryos to pseudopregnant mice which
were produced by mating the normal estrous female
mice with males with vasoligation, the pesudopregnant
mice were anesthetized by intraperitoneal injection of
sodium pentobarbital (40 mg/kg, Sigma). Then eight em-
bryos were transferred into the oviduct of a pseudopreg-
nant mouse. The mice were fed until gestational 10.5dpc
and then killed. Embryos and placentas were collected.
Statistical analysis
Data are presented as means ± SD. The methylation level
of DMRs and expression levels of genes from different
groups were compared by independent-sample t-test. A
probability level of P < 0.05 was considered significant.
Results
Methylation patterns of imprinted genes’ DMRs in
10.5dpc placentas are affected by maternal diabetes
mellitus
To understand how maternal diabetes mellitus affects
methylation levels of imprinted genes in 10.5dpc placentas
from female diabetic mice mated with normal malesfor qAMP and qRT-PCR of imprinted genes
Primer sequence
Reverse
TGGAAAGA-3′ 5′-CATAGCGGCTTCGGACATT-3′
AAGCGTCT-3′ 5′-ATTCCGGTCAGAGGGACAGA-3′
GCCCTTG-3′ 5′-CGGAGCACAGCACTCTACGC-3′
CCTTTACTTT-3′ 5′-TCCTGGGAAATGAAGTTT-3′
GAGATGATGACA-3′ 5′-ATTCTGGTATGACTCGGCATCCT-3′
GCAGGTCAT-3′ 5′-GCGGGTACTGGGTTGGGGCTC-3′
AGCCGTCTGTTC-3′ 5′- GTAGCACCATTTCTTTCATCTTGAGG-3′
GAGCTGTTTG-3′ 5′- TGTAAAGTCACCACCCTGGCACAT-3′
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ate the average methylation levels of DMRs. For paternally
imprinted gene H19, the average methylation levels were
43.92 ± 3.24% and 52.5 ± 1.42% in McrBc sites (P = 0.021),
and 46.21 ± 2.06% and 45.34 ± 1.8% in HhaI sites in dia-
betic and nondiabetic groups (Figure 1A), respectively. At
HhaI/HpaII sites, the mean methylation levels of Snrpn
were 52.62 ± 2.44%, 39.44 ± 2.45% in the diabetic group
and 47.32 ± 1.52%, 36.21 ± 1.81% in controls (Figure 1B),
respectively. In placentas, the methylation levels of DMRs
of maternally imprinted gene Peg3 were significantly al-
tered in diabetic mothers compared to controls. As shown
in Figure 1C, the average methylation levels of Peg3 in
McrBc and HpaII sites were 62.66 ± 2.33%, 53.74 ± 2.61%
and 53.82 ± 1.91%, 44.94 ± 1.49% in diabetic and non-
diabetic groups, respectively.
To confirm that qAMP is sensitive enough to evaluate
DNA methylation, we have chosen a DNA fragment in
which all CpG sites were unmethylated. We determinedFigure 1 Quantitative DNA methylation in DMRs of imprinted genes i
litters) and nondiabetic (n = 25 from 5 litters) placentas at mid-gestation w
methylation values at single and groups of restriction sites in the maternall
which were analyzed and the letter indicates the recognition sites of the e
methylation level was determined by qAMP to expected values. HhaI and M
genome. A primer pair flanking these sites was utilized to amplify DNA (NIH
genomic DNA, NEB) mixed at the ratios: 100:0, 75:25, 55:45, 50:50, 45:55, 0:1
presented as mean ± SE for each enzyme employed. White bar, non-diabetthat qAMP was sensitive enough to detect the DNA methy-
lation status for imprinted gene DMRs (Figure 1D).The average methylation levels of imprinted genes are
not altered in the fetus of diabetic females
To investigate the methylation status of imprinted
genes in dpc10.5 fetus, the methylation levels in
DMRs of maternally imprinted genes Peg3, Snrpn,
and paternally imprinted gene H19 were determined
by qAMP. The methylation pattern in DMR of H19
was not affected by maternal diabetes in the fetus
of female diabetic mice (Figure 2A). There was also
no significant difference observed in the methylation
patterns of Snrpn DMR between the diabetic and
non-diabetic embryos (Figure 2B). The average methyla-
tion level of Peg3 was similar between diabetic and non-
diabetic groups when the samples were digested by HpaII
and McrBc (Figure 2C).n 10.5dpc placentas as revealed by qAMP. Diabetic (n = 26 from 5
ere recovered. (A) The paternally methylated H19; (B, C) Percentage
y methylated DMRs of Snrpn and Peg3. The lines represent the DMRs
nzymes. M, McrBc; Hh, HhaI; Hp, HpaII. (D) Confirmation of gene
crBc sites in chr9:106724005–106724149 are unmethylated in the
3 T3 mouse genomic DNA and CpG methylated NIH 3 T3 mouse
00. The qAMP values were close to expected values. Data are
ic group; black bar, diabetic group; *P < 0.05, **P < 0.01.
Figure 2 Average DNA methylation levels in DMRs of imprinted
genes in 10.5dpc fetus as revealed by qAMP. Diabetic (n = 12
from 4 litters) and control (n = 12 from 4 litters) fetus were collected
at 10.5dpc of gestation. DNA was digested with Hha1(Hh), HpaII(Hp)
or McrBC (M) and amplified using real-time PCR. The locations of
flanked restriction sites were displayed for each DMR. (A) Shown are
the average methylation levels of paternally methylated gene H19
DMR; (B, C) represented the DNA methylation status in DMRs of
Snrpn and Peg3. Data were presented as mean ± SE for each enzyme
employed. White bar, non-diabetic group; black bar, diabetic group.
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diabetes in placentas but not in the fetus at
mid-gestation
We also assessed whether the expression levels of
imprinted genes were affected by maternal diabetes in pla-
centas and fetus at 10.5dpc by quantitative real-time PCR
(qRT-PCR). For placentas, the expression levels of Snrpn
were similar between the two groups, indicating that the
expression was not disturbed by maternal diabetes mellitus.
But expression levels of paternally imprinted gene H19 and
maternally imprinted gene Peg3 showed significant
alterations in the diabetic group compared to controls
(Figure 3A). In the fetus, the expression levels of Snrpn,
Peg3 and H19 in the diabetic groups were similar to con-
trols (Figure 3B).
We also investigated the protein expression of Peg3 in
placentas. The result showed that the protein level was
significantly lower (P = 0.039) in the diabetic group than
in the control group (Figure 3C, D). And we found that
Peg3 was expressed in the placenta (Figure 3E) and the
expression level in the control group was clearly higher
than that in the diabetic group.
Alterations of Peg3 methylation and expression in the
dpc10.5 placenta are observed in different litters
We also investigated the methylation level and mRNA
expression of Peg3 in dpc10.5 placentas between differ-
ent diabetic mothers. Six litters marked as s1-s6, respect-
ively, were analyzed. For s2, s3 and s6, methylation levels
at McrBc and HpaII were significantly higher compared
to the nondiabetic mother (Figure 4A, B). The methyla-
tion levels of s1 and s4 were clearly higher at HpaII than
the control (Figure 4B). At McrBc, the methylation level
of s5 was increased in dpc10.5 placentas of diabetic fe-
males (Figure 4A). Meanwhile, we found that the expres-
sion of Peg3 was significantly reduced by maternal
diabetes mellitus for s2, s3, s5 and s6 (Figure 4C).
The alterations of Peg3 methylation and expression may
mainly be caused by the adverse uterus environment
When pronuclear embryos of normal mothers were
transferred to diabetic/normal pseudopregnant females
(ND/NN), we found that the methylation level of Peg3
was increased in ND (Figure 5A) placentas. Meanwhile,
Figure 3 Analysis of the mRNA and protein expression levels of imprinted genes in 10.5dpc placentas and fetus. (A, B) Placentas (n = 30
from 6 litters for each group) and fetus (n = 12 from 4 litters for each group) were collected at 10.5dpc of gestation. Total RNA was purified and
reverse transferred into cDNA and then amplified using qRT-PCR. (A) Relative expression levels of H19, Snrpn and Peg3 in placentas. (B) Relative
expression levels of H19, Snrpn and Peg3 in fetus. (C) The protein expression of Peg3 in placentas (n = 6) was investigated by western blot analysis
and (D) the relative intensity of Peg3/beta-actin was evaluated by gel level analysis. (E) Placentas (n = 6) from diabetic and non-diabetic groups
were stained by anti-Peg3 at 1:500 for histological analysis. Scale bar, 100 μm. Data are presented as mean ± SD. White bar, non-diabetic group;
black bar, diabetic group; *P < 0.05, **P < 0.01.
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duced in ND (P < 0.01, Figure 5B) placentas.
When we transferred pronuclear embryos from dia-
betic/non-diabetic mice to normal pseudopregnant mice
(DN/NN), the average methylation levels in DMRs of
Peg3 were similar between DN and NN in placentas
(Figure 5C). The expression of Peg3 in placentas of NN
and DN was also similar (Figure 5D).
Discussion
Proper establishment and maintenance of DNA methyla-
tion patterns are crucial for embryo development and
survival. In the present study, we investigated whether
maternal diabetes mellitus could perturb the acquisition/
maintenance of DNA methylation during embryo devel-
opment. In our study, we found that the expressions of
Peg3 and H19 were altered in placentas at 10.5dpc; we
also identified evident changes in the methylation level
in the DMRs of them. Strikingly, these effects were not
observed when diabetic pronuclear embryos were trans-
ferred into non-diabetic recipients.
The placenta is not only the specialized organ used by
the developing embryo and fetus to obtain nutrients and
oxygen from the mother, but it also acts as a key select-
ively permeable barrier between the mother and thefetus [29]. In pregnancies complicated by pre-gestational
diabetes (type 1 and type 2), the de novo synthesis of blood
vessels in the placenta shows abnormalities [30]. Several
studies show that the expressions of leptin, leptin receptors,
androgen receptor and peroxisome proliferator-activated
receptors (PPARs) are altered by maternal diabetes mellitus
in placentas [31,32]. In our study, we also observed that the
mRNA levels of H19 and Peg3 were significantly altered in
placentas from diabetic females compared to controls.
These imprinted genes are expressed monoallelically in a
parent-of-origin specific manner. They are generally located
in clusters, epigenetically marked by DNA methylation on
differentially methylated regions (DMRs) which regulate
relative genes’ expression [33-35]. Interestingly, there were
significant changes of average methylation levels in DMRs
of H19 and Peg3 in placentas from diabetic mice. It is well
known that DNA methylation is a mechanism regulating
expression of imprinted genes. Our results indicate that ab-
normal methylation levels may be a reason for the changed
expressions of these genes. However, these changes might
be induced by different distribution of Peg3 in different pla-
cental cell populations. Hiby et al. found that Peg3 was
expressed in the trophoblast of the developing placenta at 9
days post-coitum (d.p.c.) and the trophoblast populations
of the well-developed placenta at 15 dpc [36]. In our study,
Figure 4 The methylation level and expression of Peg3 in
different litters. (A, B) the methylation level of Peg3 in different
litters (n = 6 litters) at McrBc and HpaII was analyzed by qAMP; (C)
the expression of Peg3 in s2, s3, s5 and s6 was evaluated by qRT-
PCR. White bar, nondiabetic; black bar, diabetic; number and letter
under X-axis, litter; *P < 0.05; **P < 0.01.
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relative assays. By immunohistochemistry analysis, we ob-
served that all the trophoblast populations were stained.
The Western blot analysis also indicated that the protein
level of Peg3 in diabetic placentas was obviously lower.These findings might partly elucidate how maternal dia-
betes mellitus induces abnormal embryo development, be-
cause proper DNA methylation patterns are important for
placenta and fetus development.
Previous studies found that the diabetic condition is
detrimental to pre- and post-implantation embryo devel-
opment. Congenital malformations are approximately 3–
4 times more frequent in infants from diabetic mothers
than from non-diabetic mothers [37,38]. In both
chemically induced and spontaneous diabetic models,
significant abnormalities in pre-implantation embryo de-
velopment have been observed [6,39,40]. But the DNA
methylation patterns in fetus from diabetic females are
still unclear. In our study, we examined the expression
and average methylation levels of some imprinted genes
in the placenta and embryo at 10.5dpc. We found that
the expression of relative imprinted genes was not al-
tered in diabetic dpc10.5 fetus compared with controls.
The expression of H19 was consistent with that reported
by Shao et al. [41]. The average methylation levels in
DMRs of them were also similar to controls. Although
another study found that the methylation level of H19-
Igf2 imprint control region was increased in the embry-
onic day 14 fetus from diabetic mice [41], we found that
the methylation level of H19 DMR was not affected by
maternal diabetes in the 10.5dpc embryo. Different
methods employed in these studies may be a reason for
the difference in results. Another reason may relate to
the fact that we selected different fragments as targets.
Because severe loss of DNA methylation in imprinted
genes causes embryo absorption and miscarriage during
early development, it was not possible to identify signifi-
cant loss of DNA methylation in DMRs of imprinted
genes in live fetus from diabetic females. Another reason
may be the protective function of the placenta which
serves as filter between mother and fetus. In our study,
we found no changes of imprinted genes in fetus from
mothers with diabetes mellitus, but the expression and
methylation levels were significantly affected by maternal
diabetes in placentas. These findings suggest that mater-
nal diabetes may affect fetus development by altering
placental functions.
Studies have shown that if maternal diabetes mellitus
is well controlled, the deleterious effects on embryo de-
velopment can be partially corrected. Studies also have
shown that when the diabetic females are treated with
insulin, embryo development is not significantly different
from non-diabetic females [6]. These results indicate
that the diabetic uterus environment may play a key role
in abnormal embryonic development. So we transferred
pronuclear embryos of normal females to normal/dia-
betic pseudopregnant females and found that the DNA
methylation patterns and expression of Peg3 in dpc10.5
placentas were significantly changed by the diabetic
Figure 5 DNA methylation and expression levels of Peg3 in placentas at mid-gestation. (A, B) Non-diabetic pronuclear embryos were
transferred to normal/diabetic (NN/ND) pseudopregnant female and the DNA methylation and expression levels of Peg3 (n, NN:ND = 12:15) in
10.5d placentas were analyzed by qAMP and qRT-PCR, respectively. (A) methylation level of Peg3 in dpc10.5 placenta; (B) expression of Peg3 in
placenta. (C, D) DN’s (n = 15 from 4 litters) and NN’s (n = 15 from 4 litters) placentas were collected at mid-gestation. DNA was digested with
HpaIIor McrBC and amplified using real-time PCR. (C) the methylation in DMRs of Peg3 in placentas; (D) Relative expression levels of Peg3 in
placentas. Data were presented as mean ± SD. *P < 0.05, **P < 0.01.
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of diabetic mothers were transferred to normal pseudo-
pregnant females (DN), the expression and methylation
levels of H19 and Peg3 in placentas were similar between
DN and NN. Another study has demonstrated that these
genes’ methylation status in oocytes of diabetic females
was not affected [23] at 15 days of injection of STZ. So
we propose that the altered expression and methylation
levels of imprinted genes may primarily be caused by the
adverse uterus environment of diabetic females and it
could be corrected by embryo transfer.
Conclusions
In summary, our data show that the expression of
imprinted genes is disturbed by maternal diabetes melli-
tus in mid-gestation and this may be caused by altered
methylation patterns in DMRs. Such effect could be cor-
rected by transfer of pronuclear embryos from a diabetic
mother into a normal uterus. In addition, when pro-
nuclear embryos of normal females were transferred to
diabetic pseudopregnant females, the alterations of
imprinted genes were also observed. Therefore, the det-
rimental maternal diabetic uterus environment may playa key role in causing the deleterious effects on imprinted
genes in the dpc10.5 placenta. Our evaluations of methy-
lation and expression of imprinted genes were only car-
ried out in live mid-gestation embryos and several
DMRs. The conditions regarding the entire genomic im-
printing pattern still need further clarification.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ZJG carried out the epigenetic analysis, designed the assay and wrote the
manuscript. QXL carried out the epigenetic analysis. SML, YCW and ZJG
carried out PCR amplification and epigenetic analysis. HZM participated in
analyzing the data. HS participated in revising the manuscript. QYS and CLZ
participated in the design of the assay and revising the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
We thank Yi Hou (Institute of Zoology, Chinese Academy of Sciences), and
Ying-Chun Ouyang (Institute of Zoology, Chinese Academy of Sciences) for
technical assistance.
Author details
1Reproductive Medicine Center, Henan Provincial People’s Hospital,
Zhengzhou 450003, Henan Province, P. R. China. 2Reproductive Medicine
Center, People’s Hospital of Zhengzhou University, Zhengzhou 450003,
Henan Province, P. R. China. 3State Key Laboratory of Reproductive Biology,
Ge et al. Reproductive Biology and Endocrinology 2013, 11:119 Page 9 of 9
http://www.rbej.com/content/11/1/119Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, P. R.
China. 4Department of Veterinary Pathobiology, University of Missouri,
Columbia, MO 65211, USA.
Received: 13 September 2013 Accepted: 26 December 2013
Published: 30 December 2013References
1. Yang J, Cummings EA, O’Connell C, Jangaard K: Fetal and neonatal
outcomes of diabetic pregnancies. Obstet Gynecol 2006, 108:644–650.
2. Kousseff BG: Gestational diabetes mellitus (class A): a human teratogen?
Am J Med Genet 1999, 83:402–408.
3. Loffredo CA, Wilson PD, Ferencz C: Maternal diabetes: an independent risk
factor for major cardiovascular malformations with increased mortality
of affected infants. Teratology 2001, 64:98–106.
4. Cleves MA, Hobbs CA: Collaborative strategies for unraveling the
complexity of birth defects. J Matern Fetal Neona 2004, 15:35–38.
5. Kucera J: Rate and type of congenital anomalies among offspring of
diabetic women. J Reprod Med 1971, 7:73–82.
6. Moley KH, Vaughn WK, DeCherney AH, Diamond MP: Effect of diabetes
mellitus on mouse pre-implantation embryo development. J Reprod Fertil
1991, 93:325–332.
7. Lea RG, McCracken JE, McIntyre SS, Smith W, Baird JD: Disturbed
development of the preimplantation embryo in the insulin-dependent
diabetic BB/E rat. Diabetes 1996, 45:1463–1470.
8. Baker L, Piddington R: Diabetic embryopathy: a selective review of recent
trends. J Diabetes Complications 1993, 7:204–212.
9. Corrigan N, Brazil DP, McAuliffe F: Fetal cardiac effects of maternal
hyperglycemia during pregnancy. Birth Defects Res A Clin Mol Teratol 2009,
85:523–530.
10. Phelan SA, Ito M, Loeken MR: Neural tube defects in embryos of diabetic
mice: role of the Pax-3 gene and apoptosis. Diabetes 1997, 46:1189–1197.
11. Wentzel P, Wentzel CR, Gareskog MB, Eriksson UJ: Induction of embryonic
dysmorphogenesis by high glucose concentration, disturbed inositol
metabolism, and inhibited protein kinase C activity. Teratology 2001,
63:193–201.
12. Moley KH, Chi MM, Mueckler MM: Maternal hyperglycemia alters glucose
transport and utilization in mouse preimplantation embryos. Am J Physiol
1998, 275:E38–47.
13. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB:
ATP-citrate lyase links cellular metabolism to histone acetylation.
Science 2009, 324:1076–1080.
14. Bestor TH: The DNA methyltransferases of mammals. Hum Mol Genet
2000, 9:2395–2402.
15. Reik W, Dean W, Walter J: Epigenetic reprogramming in mammalian
development. Science 2001, 293:1089–1093.
16. Bourc’his D, Xu GL, Lin CS, Bollman B, Bestor TH: Dnmt3L and the
establishment of maternal genomic imprints. Science 2001,
294:2536–2539.
17. Hata K, Okano M, Lei H, Li E: Dnmt3L cooperates with the Dnmt3 family
of de novo DNA methyltransferases to establish maternal imprints in
mice. Development 2002, 129:1983–1993.
18. Zhang TY, Labonte B, Wen XL, Turecki G, Meaney MJ: Epigenetic
mechanisms for the early environmental regulation of hippocampal
glucocorticoid receptor gene expression in rodents and humans.
Neuropsychopharmacology 2013, 38:111–123.
19. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC: Derivation of
completely cell culture-derived mice from early-passage embryonic stem
cells. Proc Natl Acad Sci U S A 1993, 90:8424–8428.
20. Moore T, Reik W: Genetic conflict in early development: parental
imprinting in normal and abnormal growth. Rev Reprod 1996, 1:73–77.
21. Dean W, Bowden L, Aitchison A, Klose J, Moore T, Meneses JJ, Reik W, Feil R:
Altered imprinted gene methylation and expression in completely ES
cell-derived mouse fetuses: association with aberrant phenotypes.
Development 1998, 125:2273–2282.
22. Davison JM, Mellott TJ, Kovacheva VP, Blusztajn JK: Gestational choline
supply regulates methylation of histone H3, expression of histone
methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA
methylation of their genes in rat fetal liver and brain. J Biol Chem 2009,
284:1982–1989.23. Ge ZJ, Liang XW, Guo L, Liang QX, Luo SM, Wang YP, Wei YC, Han ZM,
Schatten H, Sun QY: Maternal diabetes causes alterations of DNA
methylation statuses of some imprinted genes in murine oocytes.
Biol Reprod 2013, 88:117.
24. Pearson DWM, Kernaghan D, Lee R, Penney GC, Scottish Diabetes in
Pregnancy Study G: The relationship between pre-pregnancy care and
early pregnancy loss, major congenital anomaly or perinatal death in
type I diabetes mellitus. BJOG 2007, 114:104–107.
25. Wang Q, Ratchford AM, Chi MMY, Schoeller E, Frolova A, Schedl T, Moley
KH: Maternal diabetes causes mitochondrial dysfunction and meiotic
defects in murine oocytes. Mol Endocrinol 2009, 23:1603–1612.
26. Oakes CC, La Salle S, Robaire B, Trasler JM: Evaluation of a quantitative
DNA methylation analysis technique using methylation-sensitive/
dependent restriction enzymes and real-time PCR. Epigenetics 2006,
1:146–152.
27. Lopes FL, Fortier AL, Darricarrere N, Chan D, Arnold DR, Trasler JM:
Reproductive and epigenetic outcomes associated with aging mouse
oocytes. Hum Mol Genet 2009, 18:2032–2044.
28. Huang L, Wang ZB, Jiang ZZ, Hu MW, Lin F, Zhang QH, Luo YB, Hou Y, Zhao
Y, Fan HY, et al: Specific disruption of Tsc1 in ovarian granulosa cells
promotes ovulation and causes progressive accumulation of corpora
lutea. PLoS One 2013, 8:e54052.
29. Leach L: Placental vascular dysfunction in diabetic pregnancies:
intimations of fetal cardiovascular disease? Microcirculation 2011,
18:263–269.
30. Leach L, Babawale MO, Anderson M, Lammiman M: Vasculogenesis,
angiogenesis and the molecular organisation of endothelial junctions in
the early human placenta. J Vasc Res 2002, 39:246–259.
31. Uzelac PS, Li X, Lin J, Neese LD, Lin L, Nakajima ST, Bohler H, Lei Z:
Dysregulation of leptin and testosterone production and their receptor
expression in the human placenta with gestational diabetes mellitus.
Placenta 2010, 31:581–588.
32. Kurtz M, Capobianco E, Martinez N, Fernandez J, Higa R, White V,
Jawerbaum A: Carbaprostacyclin, a PPARdelta agonist, ameliorates excess
lipid accumulation in diabetic rat placentas. Life Sci 2010, 86:781–790.
33. Holmes R, Soloway PD: Regulation of imprinted DNA methylation.
Cytogenet Genome Res 2006, 113:122–129.
34. Lewis A, Reik W: How imprinting centres work. Cytogenet Genome Res
2006, 113:81–89.
35. Fauque P, Ripoche M-A, Tost J, Journot L, Gabory A, Busato F, Le Digarcher
A, Mondon F, Gut I, Jouannet P, et al: Modulation of imprinted gene
network in placenta results in normal development of in vitro
manipulated mouse embryos. Hum Mol Genet 2010, 19:1779–1790.
36. Hiby SE, Lough M, Keverne EB, Surani MA, Loke YW, King A: Paternal
monoallelic expression of PEG3 in the human placenta. Hum Mol Genet
2001, 10:1093–1100.
37. Eriksson UJ: Congenital malformations in diabetic animal models–a
review. Diabetes Res 1984, 1:57–66.
38. Becerra JE, Khoury MJ, Cordero JF, Erickson JD: Diabetes mellitus during
pregnancy and the risks for specific birth defects: a population-based
case–control study. Pediatrics 1990, 85:1–9.
39. Diamond MP, Lavy G, Polan ML: Progesterone production from granulosa
cells of individual human follicles derived from diabetic and nondiabetic
subjects. Int J Fertil 1989, 34:204–208.
40. Vercheval M, De Hertogh R, Pampfer S, Vanderheyden I, Michiels B, De
Bernardi P, De Meyer R: Experimental diabetes impairs rat embryo
development during the preimplantation period. Diabetologia 1990,
33:187–191.
41. Shao W-J, Tao L-Y, Gao C, Xie J-Y, Zhao R-Q: Alterations in methylation
and expression levels of imprinted genes H19 and Igf2 in the fetuses of
diabetic mice. Comp Med 2008, 58:341–346.
doi:10.1186/1477-7827-11-119
Cite this article as: Ge et al.: Diabetic uterus environment may play a
key role in alterations of DNA methylation of several imprinted genes at
mid-gestation in mice. Reproductive Biology and Endocrinology
2013 11:119.
